Cargando…
A Randomized Trial of Split Dose 3 L Polyethylene Glycol Lavage Solution, 2 L Polyethylene Glycol Lavage Combined With Castor Oil, and 1 L of Polyethylene Glycol Lavage Solution Combined With Castor Oil and Ascorbic Acid for Preparation for Colonoscopy
Background: Castor oil (CaO) has the potential of halving the required volume of bowel preparation solution; however, no clinical trial investigated the efficacy of CaO on bowel preparation for colonoscopy in addition to polyethylene glycol (PEG). Objectives: Our aim was to evaluate efficacy and saf...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6624777/ https://www.ncbi.nlm.nih.gov/pubmed/31334239 http://dx.doi.org/10.3389/fmed.2019.00158 |
_version_ | 1783434288266477568 |
---|---|
author | Tian, Xu Shi, Bing Liu, Xiao-Ling Chen, Hui Chen, Wei-Qing |
author_facet | Tian, Xu Shi, Bing Liu, Xiao-Ling Chen, Hui Chen, Wei-Qing |
author_sort | Tian, Xu |
collection | PubMed |
description | Background: Castor oil (CaO) has the potential of halving the required volume of bowel preparation solution; however, no clinical trial investigated the efficacy of CaO on bowel preparation for colonoscopy in addition to polyethylene glycol (PEG). Objectives: Our aim was to evaluate efficacy and safety of lower dose PEG together with 30 mL CaO alone or plus ascorbic acid (Asc) in bowel preparation before colonoscopy. Methods: Two hundred and forty-six patients were allocated randomly to ingest 2 L PEG with 30 mL CaO, 1 L PEG with 30 mL CaO plus 5 g Asc, or 3 L PEG. We used Boston Bowel Preparation Scale (BBPS) to evaluate bowel preparation efficacy. We also determined other outcomes such as procedure time, polyp or adenoma detection rate, and adverse events (AEs). Results: Of 282 patients recruited, 36 were excluded. Groups were matched for baseline characteristics except weight (P = 0.020) and body mass index (BMI) (P = 0.003). Patient's satisfaction was higher in 2 L PEG-CaO (P = 0.016) and 1 L PEG-CaO-Asc groups (P = 0·017). Patients' compliance was 67.5, 71.4, and 80.5% in 3 L PEG, 2 L PEG-CaO, and 1 L PEG-CaO-Asc groups (P = 0.014). Adequate bowel preparation rate was 75, 78.57, and 53.66% in 3 L PEG, 2 L PEG-CaO, and 1 L PEG-CaO-Asc groups (P = 0.021). There were no differences in terms of remaining outcomes. Conclusions: Despite an increase in patients' satisfaction and compliance, 1 L PEG-CaO-Asc significantly decreased adequate bowel preparation rate. However, 2 L PEG-CaO improved the patients' satisfaction and compliance and increased adequate bowel preparation rate (Registration number, ChiCTR-IIR-17012418). |
format | Online Article Text |
id | pubmed-6624777 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-66247772019-07-22 A Randomized Trial of Split Dose 3 L Polyethylene Glycol Lavage Solution, 2 L Polyethylene Glycol Lavage Combined With Castor Oil, and 1 L of Polyethylene Glycol Lavage Solution Combined With Castor Oil and Ascorbic Acid for Preparation for Colonoscopy Tian, Xu Shi, Bing Liu, Xiao-Ling Chen, Hui Chen, Wei-Qing Front Med (Lausanne) Medicine Background: Castor oil (CaO) has the potential of halving the required volume of bowel preparation solution; however, no clinical trial investigated the efficacy of CaO on bowel preparation for colonoscopy in addition to polyethylene glycol (PEG). Objectives: Our aim was to evaluate efficacy and safety of lower dose PEG together with 30 mL CaO alone or plus ascorbic acid (Asc) in bowel preparation before colonoscopy. Methods: Two hundred and forty-six patients were allocated randomly to ingest 2 L PEG with 30 mL CaO, 1 L PEG with 30 mL CaO plus 5 g Asc, or 3 L PEG. We used Boston Bowel Preparation Scale (BBPS) to evaluate bowel preparation efficacy. We also determined other outcomes such as procedure time, polyp or adenoma detection rate, and adverse events (AEs). Results: Of 282 patients recruited, 36 were excluded. Groups were matched for baseline characteristics except weight (P = 0.020) and body mass index (BMI) (P = 0.003). Patient's satisfaction was higher in 2 L PEG-CaO (P = 0.016) and 1 L PEG-CaO-Asc groups (P = 0·017). Patients' compliance was 67.5, 71.4, and 80.5% in 3 L PEG, 2 L PEG-CaO, and 1 L PEG-CaO-Asc groups (P = 0.014). Adequate bowel preparation rate was 75, 78.57, and 53.66% in 3 L PEG, 2 L PEG-CaO, and 1 L PEG-CaO-Asc groups (P = 0.021). There were no differences in terms of remaining outcomes. Conclusions: Despite an increase in patients' satisfaction and compliance, 1 L PEG-CaO-Asc significantly decreased adequate bowel preparation rate. However, 2 L PEG-CaO improved the patients' satisfaction and compliance and increased adequate bowel preparation rate (Registration number, ChiCTR-IIR-17012418). Frontiers Media S.A. 2019-07-05 /pmc/articles/PMC6624777/ /pubmed/31334239 http://dx.doi.org/10.3389/fmed.2019.00158 Text en Copyright © 2019 Tian, Shi, Liu, Chen and Chen. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Medicine Tian, Xu Shi, Bing Liu, Xiao-Ling Chen, Hui Chen, Wei-Qing A Randomized Trial of Split Dose 3 L Polyethylene Glycol Lavage Solution, 2 L Polyethylene Glycol Lavage Combined With Castor Oil, and 1 L of Polyethylene Glycol Lavage Solution Combined With Castor Oil and Ascorbic Acid for Preparation for Colonoscopy |
title | A Randomized Trial of Split Dose 3 L Polyethylene Glycol Lavage Solution, 2 L Polyethylene Glycol Lavage Combined With Castor Oil, and 1 L of Polyethylene Glycol Lavage Solution Combined With Castor Oil and Ascorbic Acid for Preparation for Colonoscopy |
title_full | A Randomized Trial of Split Dose 3 L Polyethylene Glycol Lavage Solution, 2 L Polyethylene Glycol Lavage Combined With Castor Oil, and 1 L of Polyethylene Glycol Lavage Solution Combined With Castor Oil and Ascorbic Acid for Preparation for Colonoscopy |
title_fullStr | A Randomized Trial of Split Dose 3 L Polyethylene Glycol Lavage Solution, 2 L Polyethylene Glycol Lavage Combined With Castor Oil, and 1 L of Polyethylene Glycol Lavage Solution Combined With Castor Oil and Ascorbic Acid for Preparation for Colonoscopy |
title_full_unstemmed | A Randomized Trial of Split Dose 3 L Polyethylene Glycol Lavage Solution, 2 L Polyethylene Glycol Lavage Combined With Castor Oil, and 1 L of Polyethylene Glycol Lavage Solution Combined With Castor Oil and Ascorbic Acid for Preparation for Colonoscopy |
title_short | A Randomized Trial of Split Dose 3 L Polyethylene Glycol Lavage Solution, 2 L Polyethylene Glycol Lavage Combined With Castor Oil, and 1 L of Polyethylene Glycol Lavage Solution Combined With Castor Oil and Ascorbic Acid for Preparation for Colonoscopy |
title_sort | randomized trial of split dose 3 l polyethylene glycol lavage solution, 2 l polyethylene glycol lavage combined with castor oil, and 1 l of polyethylene glycol lavage solution combined with castor oil and ascorbic acid for preparation for colonoscopy |
topic | Medicine |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6624777/ https://www.ncbi.nlm.nih.gov/pubmed/31334239 http://dx.doi.org/10.3389/fmed.2019.00158 |
work_keys_str_mv | AT tianxu arandomizedtrialofsplitdose3lpolyethyleneglycollavagesolution2lpolyethyleneglycollavagecombinedwithcastoroiland1lofpolyethyleneglycollavagesolutioncombinedwithcastoroilandascorbicacidforpreparationforcolonoscopy AT shibing arandomizedtrialofsplitdose3lpolyethyleneglycollavagesolution2lpolyethyleneglycollavagecombinedwithcastoroiland1lofpolyethyleneglycollavagesolutioncombinedwithcastoroilandascorbicacidforpreparationforcolonoscopy AT liuxiaoling arandomizedtrialofsplitdose3lpolyethyleneglycollavagesolution2lpolyethyleneglycollavagecombinedwithcastoroiland1lofpolyethyleneglycollavagesolutioncombinedwithcastoroilandascorbicacidforpreparationforcolonoscopy AT chenhui arandomizedtrialofsplitdose3lpolyethyleneglycollavagesolution2lpolyethyleneglycollavagecombinedwithcastoroiland1lofpolyethyleneglycollavagesolutioncombinedwithcastoroilandascorbicacidforpreparationforcolonoscopy AT chenweiqing arandomizedtrialofsplitdose3lpolyethyleneglycollavagesolution2lpolyethyleneglycollavagecombinedwithcastoroiland1lofpolyethyleneglycollavagesolutioncombinedwithcastoroilandascorbicacidforpreparationforcolonoscopy AT tianxu randomizedtrialofsplitdose3lpolyethyleneglycollavagesolution2lpolyethyleneglycollavagecombinedwithcastoroiland1lofpolyethyleneglycollavagesolutioncombinedwithcastoroilandascorbicacidforpreparationforcolonoscopy AT shibing randomizedtrialofsplitdose3lpolyethyleneglycollavagesolution2lpolyethyleneglycollavagecombinedwithcastoroiland1lofpolyethyleneglycollavagesolutioncombinedwithcastoroilandascorbicacidforpreparationforcolonoscopy AT liuxiaoling randomizedtrialofsplitdose3lpolyethyleneglycollavagesolution2lpolyethyleneglycollavagecombinedwithcastoroiland1lofpolyethyleneglycollavagesolutioncombinedwithcastoroilandascorbicacidforpreparationforcolonoscopy AT chenhui randomizedtrialofsplitdose3lpolyethyleneglycollavagesolution2lpolyethyleneglycollavagecombinedwithcastoroiland1lofpolyethyleneglycollavagesolutioncombinedwithcastoroilandascorbicacidforpreparationforcolonoscopy AT chenweiqing randomizedtrialofsplitdose3lpolyethyleneglycollavagesolution2lpolyethyleneglycollavagecombinedwithcastoroiland1lofpolyethyleneglycollavagesolutioncombinedwithcastoroilandascorbicacidforpreparationforcolonoscopy |